Company: NKLR
Filing Date: 2025-06-26
Form Type: S-4/A
Source: 0001213900-25-058019
Chunk: 645

Company: Terra Innovatum Global N.V.
Filing Date: 2025-06-26
Form: S-4/A
Chunk 645
---
 we deemed necessary and appropriate to our analysis; and j. Publicly available financial information of GSRT, including GSRT’s filings with the U.S. Securities and Exchange Commission (the “SEC”). 2)We met or otherwise communicated electronically with certain members of GSRT’s and Terra Innovatum’s senior and operating management to discuss Terra Innovatum’s operations, historical financial results related to their entities, future prospects, and projected operations and performance; 3)We considered publicly available data and stock market performance data of public companies we deem comparable to Terra Innovatum and reviewed the industry and geography in which Terra Innovatum operates; 4)We considered, to the extent publicly available, the financial terms of certain other transactions which we considered relevant in evaluating the Transaction; and 5)We conducted such other studies, analyses, inquiries, and investigations as we deemed appropriate, including economic, industry, geographical and Company- specific information. The primary method used was a Market Method – Guideline Public Traded Companies as the basis for the fairness opinion assessment. These public comps were independently obtained by us. The Guideline Publicly Traded Companies method involves selecting a subset of companies within the same GICS category that operate in a similar industry and share comparable characteristics. Management also provided comparable companies that were reviewed as secondary comparison and found overlaps while conducting the fairness opinion assessment. We also used a Guideline Transaction Method to support the fairness opinion assessment. These were independently obtained and examined by us. Additional details of the analysis performed can be found in the associated proxy statement. In the course of our investigation, we have assumed and relied upon the accuracy and completeness of the financial statements, forecasts related to the unit level economics and regulatory approval plan, and other information provided to us by GSRT and the Company and we have further relied upon the assurances of management that they were unaware of any facts that would make the information provided to us incomplete or misleading in any material Annex E-2 respect for the purposes of this Opinion. We have not assumed any responsibility for independent verification of such information or assurances. With respect to the Terra Innovatum company outlook, we have been advised by Terra Innovatum, and have assumed, that they have been reasonably prepared on bases reflecting the good faith judgement of the management of Terra Innovatum as to the future financial performance of Terra Innovatum. Given GSRT’s nature as a special purpose acquisition company, for purposes of our opinion and with GSRT’s consent, we have assumed a value of $10.00 per share in calculating the value of the